Cas:1420867-93-1 1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid manufacturer & supplier

Chemical Name:1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid

CAS.NO:1420867-93-1

Synonyms:1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid

Molecular Formula:C₉H₉BrN₂O₂

Molecular Weight:257.08400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:53.43000

Exact Mass:255.98500

LogP:1.42990

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid Use and application,1-(5-bromopyridin-2-yl)azetidine-3-carboxylic acid technical grade,usp/ep/jp grade.

Related News: In 2018, the Bengaluru-based Natural Capsules set up an R&D centre in at Attibele, Bengaluru. In 2020, when PLI scheme was announced it applied for the same. [Ti((η5-C5H4)B(N(i)Pr2)N(H)(t)Bu)(NMe2)3] manufacturers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 2,10-dimethyl-9,11-dinitro-12H-pyrano[2,3-a]phenoxazin-4-one suppliers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. Gastric inhibitory polypeptide (human), 2-L-serine- vendor & factory.